Heparan sulfate proteoglycans and viral attachment: true receptors or adaptation bias?

V Cagno, ED Tseligka, ST Jones, C Tapparel - Viruses, 2019 - mdpi.com
Heparan sulfate proteoglycans (HSPG) are composed of unbranched, negatively charged
heparan sulfate (HS) polysaccharides attached to a variety of cell surface or extracellular …

Respiratory syncytial virus: infection, detection, and new options for prevention and treatment

C Griffiths, SJ Drews, DJ Marchant - Clinical microbiology reviews, 2017 - Am Soc Microbiol
Respiratory syncytial virus (RSV) infection is a significant cause of hospitalization of children
in North America and one of the leading causes of death of infants less than 1 year of age …

Type I and type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures

A Vanderheiden, P Ralfs, T Chirkova… - Journal of …, 2020 - Am Soc Microbiol
The newly emerged human coronavirus, severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), has caused a pandemic of respiratory illness. Current evidence suggests …

Respiratory syncytial virus entry and how to block it

MB Battles, JS McLellan - Nature Reviews Microbiology, 2019 - nature.com
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract disease in
young children and elderly people. Although the virus was isolated in 1955, an effective …

First contact: the role of respiratory cilia in host-pathogen interactions in the airways

LE Kuek, RJ Lee - … Journal of Physiology-Lung Cellular and …, 2020 - journals.physiology.org
Respiratory cilia are the driving force of the mucociliary escalator, working in conjunction
with secreted airway mucus to clear inhaled debris and pathogens from the conducting …

Immunopathology of RSV: an updated review

HC Bergeron, RA Tripp - Viruses, 2021 - mdpi.com
RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has
limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding …

Protective and harmful immunity to RSV infection

PJM Openshaw, C Chiu, FJ Culley… - Annual review of …, 2017 - annualreviews.org
Respiratory syncytial virus (RSV) is an exceptional mucosal pathogen. It specializes in
infection of the ciliated respiratory epithelium, causing disease of variable severity with little …

Immunological lessons from respiratory syncytial virus vaccine development

TJ Ruckwardt, KM Morabito, BS Graham - Immunity, 2019 - cell.com
Respiratory syncytial virus (RSV) has eluded active vaccination efforts for more than five
decades and continues to cause substantial morbidity and mortality in infants, the …

Innate immunity of the lung: from basic mechanisms to translational medicine

D Hartl, R Tirouvanziam, J Laval, CM Greene… - Journal of innate …, 2018 - karger.com
The respiratory tract is faced daily with 10,000 L of inhaled air. While the majority of air
contains harmless environmental components, the pulmonary immune system also has to …

Airway epithelium dysfunction in cystic fibrosis and COPD

V De Rose, K Molloy, S Gohy, C Pilette… - Mediators of …, 2018 - Wiley Online Library
Cystic fibrosis is a genetic disease caused by mutations in the CFTR gene, whereas chronic
obstructive pulmonary disease (COPD) is mainly caused by environmental factors (mostly …